Novome Biotechnologies is a DCVC-backed biotechnology company based in South San Francisco developing genetically engineered microbial medicines (GEMMs) - live bacterial therapeutics designed to colonize the gut and treat chronic conditions such as enteric hyperoxaluria and other GI and metabolic diseases. - View it on GitHub